Diagnostic Tests for SARS-CoV-2: Implications in Head and Neck Oncology.Oral Oncol. 2020 08; 107:104813.OO
Links
MeSH
Antibodies, ViralBetacoronavirusCOVID-19COVID-19 TestingClinical Laboratory TechniquesCoronavirus InfectionsEarly DiagnosisGingival Crevicular FluidHead and Neck NeoplasmsHealth PersonnelHumansInfection ControlInfectious Disease Transmission, Patient-to-ProfessionalInfectious Disease Transmission, Professional-to-PatientMass ScreeningOtorhinolaryngologic Surgical ProceduresPandemicsPersonal Protective EquipmentPneumonia, ViralRNA, ViralSARS-CoV-2SalivaSurgical Oncology
Pub Type(s)
Letter
Language
eng
PubMed ID
32471801
Citation
Kochhar, Anuraj Singh, et al. "Diagnostic Tests for SARS-CoV-2: Implications in Head and Neck Oncology." Oral Oncology, vol. 107, 2020, p. 104813.
Kochhar AS, Bhasin R, Kochhar GK, et al. Diagnostic Tests for SARS-CoV-2: Implications in Head and Neck Oncology. Oral Oncol. 2020;107:104813.
Kochhar, A. S., Bhasin, R., Kochhar, G. K., & Dadlani, H. (2020). Diagnostic Tests for SARS-CoV-2: Implications in Head and Neck Oncology. Oral Oncology, 107, 104813. https://doi.org/10.1016/j.oraloncology.2020.104813
Kochhar AS, et al. Diagnostic Tests for SARS-CoV-2: Implications in Head and Neck Oncology. Oral Oncol. 2020;107:104813. PubMed PMID: 32471801.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Diagnostic Tests for SARS-CoV-2: Implications in Head and Neck Oncology.
AU - Kochhar,Anuraj Singh,
AU - Bhasin,Ritasha,
AU - Kochhar,Gulsheen Kaur,
AU - Dadlani,Himanshu,
Y1 - 2020/05/21/
PY - 2020/05/16/received
PY - 2020/05/19/accepted
PY - 2020/5/31/pubmed
PY - 2020/8/8/medline
PY - 2020/5/31/entrez
SP - 104813
EP - 104813
JF - Oral oncology
JO - Oral Oncol
VL - 107
SN - 1879-0593
UR - https://www.unboundmedicine.com/medline/citation/32471801/Diagnostic_Tests_for_SARS_CoV_2:_Implications_in_Head_and_Neck_Oncology_
DB - PRIME
DP - Unbound Medicine
ER -